Carl Spear, OD, MBA Joins Luxottica as Senior Vice President, Eyecare

Life Science Partner is pleased to announce the recruitment of Carl Spear, OD, MBA, to serve as Senior Vice President, Eyecare for Luxottica, the world’s largest eyeware company.

Luxottica is a leader in the design, manufacture and distribution of fashion, luxury, sports and performance eyewear. Of Luxottica’s 80,000 employees, more than 5,000 are US-based Doctors of Optometry providing patient care and business leadership at LensCrafters, Pearle Vision, Sears Optical, and Target Optical retail stores across the nation.

Luxottica is the world’s leading consumer eyecare group, with proprietary brands such as Ray-Ban, Oakley, Persol, Oliver Peoples, Alain Mikli and Arnette, as well as licensed brands including Giorgio Armani, Burberry, Bulgari, Chanel, Dolce&Gabbana, Michael Kors, Prada, Ralph Lauren, Tiffany & Co., and Versace.

A merger is underway between Luxottica and Essilor, the world’s leading manufacturer of ophthalmic lenses.

Dr. Spear will report directly to the Chief Executive Officer and will be responsible for the strategic recruitment, development, and retention of Luxottica’s optometrist community while maximizing the economic return of resources allocated among the Company’s retail brands.

Previously, Spear served as Senior Director, Professional Services for Vision Group Holdings, where he recruited and managed the contracting of ophthalmologists and optometrists to staff their 75 refractory and cataract surgery centers. In parallel, he held a consulting role overseeing the professional affairs strategy for Alcon, the eyecare subsidiary of Novartis.

Before joining industry, Spear spent more than 20 years in private optometry practice. He also served in the United States Air Force as Company Commander for a special operations team in Iraq.

“Carl brings the clinical and industry insights to help Luxottica shape how consumer Eyecare is delivered in the years to come,” said Tom Callway, MD, MBA, President of Life Science Partner. “His tremendous network and deep experience in the space will serve him well as he develops strategies to ensure Luxottica attracts and retains best-in-class clinical talent during this critical period for the company.”

Spear earned his Doctorate of Optometry from the University of Alabama School of Optometry with a residency in Primary Care and Ocular Disease from Northeastern State University College of Optometry. He also earned an MBA from Auburn University and a bachelor’s degree in Biology from Western Kentucky University.

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

 

 

Barbara Benedict Joins Notal Vision as Director, Patient Engagement

Life Science Partner is pleased to announce the recruitment of Barbara Benedict to Notal Vision as Director of Patient Engagement.

Notal Vision is a tele-health company offering the first patient-initiated, home-based monitoring system to prevent the progression of macular degeneration through early detection and intervention. The technology combines a physical device with a data management infrastructure and a cloud-based physician monitoring system.

In her new role, Benedict will have broad responsibility over all operational aspects of the customer experience, developing key patient engagement strategies and ensuring an exceptional experience for patients and their caregivers.

Previously, Benedict led customer engagement and marketing at Conifer Health, the healthcare management services subsidiary of Tenet Health. Prior to joining Conifer Health Solutions, Benedict spent 4 years in enterprise physician marketing and communications for BayCare Health System, a health care system connecting patients to a wide range of services at 14 hospitals throughout central Florida. She also spent three years as Director, Customer Relations, Marketing and Operations at Healthcare Partners, which manages and administers healthcare products for contracted health plans. Here she led operations for a large multi-specialty medical clinic including a comprehensive customer relations program and community engagement program.

“Barbara has demonstrated she knows how to use remote monitoring technologies to keep patients well, and that she can build and enact a strategy for ensuring these patients are engaged and supported throughout the entire patient journey,” notes Tom Callaway, MD, MBA, President of Life Science Partner. “Her blend of patient-centered empathy and healthcare operations rigor make her a great match for this important role.”

Benedict earned a degree in Marketing and Business Development from the University of South Florida.

 

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

K2M Recruits Caltlyn Seidl to be Director, Clinical & Regulatory Affairs

Life Science Partner is pleased to announce the recruitment of Caitlyn Seidl to K2M, where she will serve as Director, Regulatory & Clinical Affairs.

Based in Leesburg, Virginia, K2M is a medical device company focused on creating tools and implants for minimally-invasive spine surgery. The company is a leader in the 3D printing of spinal implants for deformity (especially scoliosis), trauma, and tumor operations. Reporting to the Senior Vice President of Global Quality and Regulatory Affairs, Seidl will be responsible for directing global clinical outcomes research programs and the global regulatory process for K2M’s product portfolio.

Previously, Seidl served as Manager, Clinical Affairs for the Critical Care division of Edwards Lifesciences, a leader in artificial heart valves and related technologies. Seidl has also held clinical affairs leadership positions with Exactech (orthopedic devices), Axogen (biologics), and Cardioquest (cardiovascular research). She brings to K2M more than a decade of clinical and regulatory affairs leadership including trials in spinal orthopedics.

“Caitlyn impressed us as a leader with both the technical acumen in clinical trials for spinal orthopedic devices and the team management skills to ensure the group’s clinical studies faithfully convey the value K2M’s technologies bring to patients,” shared Tom Callaway, MD, MBA, President of Life Science Partner. “She will be a great asset to K2M and we look forward to seeing her impact over the coming years.”

Seidly earned her bachelor’s degree in Biomedical Sciences from the University of South Florida.

 

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Mark Alvarez Joins Irrimax as Chief Executive Officer

Life Science Partner is pleased to announce the recruitment of Mark Alvarez to Irrimax, where he will serve as Chief Executive Officer.

Irrimax is an Atlanta-based medical technology company that is redefining wound irrigation with Irrisept, the only FDA-cleared medical device for irrigation containing the proven antiseptic chlorhexidine gluconate (CHG).

Alvarez was most recently Chairman, President & CEO of BC Technical, a healthcare services company focused on diagnostic imaging solutions for hospitals & clinics across the US. BCT was acquired in 2017 by Alpha Source, a portfolio company of Baird Capital. Prior to his BC Technical role, Mark was Chairman-Elect & COO of Microtek Medical (Nasdaq:MTMD), a global manufacturer of custom infection control products acquired by Ecolab.

“Mark is a high-energy executive who has demonstrated the ability to fund, grow, and sell small to mid-sized healthcare companies but also has held P&L responsibility in a large global medtech organization,” commented Tom Callaway, MD, MBA, President of Life Science Partner. “His strategic experience in the infection control space will be indispensable to Irrimax during this important inflection point in the company’s growth.”

Alvarez earned a MBA from Illinois State University, a Bachelor’s degree in Biology from the University of Louisville, and has completed multiple executive programs at the GE Leadership Institute. He is a former professional tennis player and lives in Atlanta.

 

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Frank Stokes Joins Castle Biosciences as Chief Financial Officer

Life Science Partner is pleased to announce the recruitment of Frank Stokes to Castle Biosciences as Chief Financial Officer.

Castle Biosciences is a molecular diagnostics company dedicated to helping patients and their physicians make the best possible decisions about their treatment and follow up care based on the individual molecular signature of their tumor. The Company currently offers tests for patients with cutaneous melanoma and uveal melanoma, with development programs in other underserved cancers.

Stokes previously served as Chief Financial Officer for Hammock Pharmaceuticals, maker of therapies for women’s health and urology. Prior, he was a senior investment banker at Leerink Swan, where he focused principally on diagnostics and biopharmaceuticals.

“Frank brings financial acumen, expertise in capital markets, success with mergers and acquisitions, and a deep knowledge of the diagnostics industry—all of which will help our team continue our mission to improve patient care decisions and deliver shareholder value,” commented Derek Maetzold, President and CEO of Castle Biosciences. “With two commercial products, a robust pipeline, and a strong base of clinical data, Castle Biosciences is well-positioned to leverage his strengths as we target our combined U.S. market opportunity of nearly $2 billion and continue to deliver strong growth in revenue and test volumes.”

Stokes received a B.S. in business administration followed by MBA and J.D. degrees from the University of North Carolina at Chapel Hill.

 

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Leica Biosystems Recruits Dan Schrock to Senior Director, Global Clinical Affairs

Life Science Partner is pleased to announce the recruitment of Dan Schrock to Leica Biosystems to serve as Senior Director, Global Clinical Affairs.

Leica Biosystems is a global leader in clinical diagnostics technologies providing a full suite of anatomic pathology products and laboratory workflow solutions for cancer diagnostics. Utilizing this platform, the company provides customized companion diagnostics solutions for pharmaceutical companies developing novel oncology drugs. Leica Biosystems is part of the Danaher group of companies.

Schrock previously served as Sr. Manager, Alliances with Illumina in San Diego, where he was responsible for managing corporate partnerships for the development of companion diagnostics for oncology drugs. Prior, Schrock led clinical affairs programs in IVD and CDx with Ventana Medical Systems, Abbott Laboratories, and Cepheid.

In his new role, Schrock will be responsible for overseeing Leica’s clinical research programs, providing strategic leadership to the company’s evolving clinical affairs function, and managing partnerships with pharmaceutical companies for the continued development and testing of companion diagnostics for personalized medicine.

“Companion diagnostics development is core to the Leica’s clinical strategy, so this leader must have a solid grounding in not only clinical trials leadership, but also diagnostics development and pharmaceutical partnering. It’s quite rare to see this combination of clinical trials excellence and CDx expertise in the same individual,” noted Tom Callaway, MD, MBA, President of Life Science Partner. “Dan is ideally suited for this important role and we expect him to be an asset to the company for many years to come.”

Schrock is a chemist by training and earned his Bachelors and Masters degrees in Chemistry from Illinois State University.

 

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Fred Siebert Joins Beckman Coulter as Director, Global Clinical Affairs

Life Science Partner is pleased to announce the recruitment of Fred Siebert to Beckman Coulter as Director, Global Clinical Affairs. Beckman Coulter is an innovative diagnostics and life science company that creates the world’s most efficient diagnostic laboratories. It is part of the Danaher group of families.

In this new role, Siebert will be responsible for the development and execution of a consolidated global clinical trials strategy for the company. This work is of particular importance to the company in the context of changing European regulatory requirements and continued growth of the company’s clinical activities in Asia.

Siebert brings deep experience in global clinical trials for molecular diagnostics and biopharmaceuticals, most recently at OvaScience, where he oversaw their clinical programs as Vice President of Clinical Operations.

Earlier in his career, Siebert held a variety of clinical affairs leadership roles at Abbott Molecular, where he led the company’s first companion diagnostics partnership and earned the Abbot Chairman’s Award for his contributions.

“Fred in in a great position to leverage his clinical insights and global diagnostics experience to further Beckman Coulter’s global leadership in IVD,“ notes Tom Callaway, MD, President and Founding Partner at Life Science Partner. “We look forward to seeing the continued growth and geographical expansion of the company’s clinical programs under his able leadership.”

Siebert earned a BSc in Medical Technology  from Eastern Kentucky University.

 

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

Max Wallace Recognized with Life Sciences Achievement Award

Life Science Partner congratulates Max Wallace on his recognition with the CED Life Science Leadership Award for his contributions to the life sciences industry in North Carolina and more broadly.

Image result for max wallaceMr. Wallace currently serves as CEO of Accelerate Brain Cancer Cure (ABC²), a venture philanthropy organization that has helped bring 30 new brain cancer treatments into the clinic. Life Science Partner recruited him to this post several years ago because of his deep experience bringing impactful treatments to patients. He previously was CEO of TheraLogics, an anti-cancer company based on technology from the University of North Carolina. He also co-founded and served as President of Trimeris, a public company that developed Fuzeon, the first FDA-approved viral entry inhibitor, establishing a whole new class of drugs for HIV/AIDS and other viral diseases.

Watch Mr. Wallace’s acceptance here and read more here.

Pamela Goldberg Joins Medical Device Innovation Consortium as President, CEO

Life Science Partner is pleased to announce the recruitment of Pamela Goldberg to lead the Medical Device Innovation Consortium as President and Chief Executive Officer.

Image result for pamela goldberg

Prior to starting her own consulting firm in 2017, Ms. Goldberg served as the CEO of the Massachusetts Technology Collaboration, a public economic development engine designed to foster technological advancements, where she helped launch Massachusetts to national leadership for adoption and interoperability of electronic medical records and collaborated to build the health information exchange connection to the EHR.

She will succeed Bill Murray as CEO, whom Life Science Partner recruited at the organization’s inception, and is well-suited to lead MDIC into its next phase of growth and impact, building on the foundational successes of Mr. Murray and his team.

“Pamela’s solid entrepreneurial experience synergizing objectives for multiple government and for-profit institutions, combined with her successful leadership experience in digital health advancements, leveraging big data, and advancing healthcare technological innovation, make her uniquely suited to lead this pioneering organization,” said Tom Callaway, MD, Founder and President of Life Science Partner. “We are confident MDIC and the many stakeholders it serves will benefit greatly from her thoughtful leadership in the months and years to come.”

Ms. Goldberg has demonstrated consistent success in working across the boundaries of government, in both non-profit and private industry and with regulatory bodies to drive consensus. Previously, Ms. Goldberg served as director of The Center for Entrepreneurial Leadership at Tufts University, a program she launched to drive innovation for the university. Ms. Goldberg received her BA from Tufts University and her MBA from Stanford University.

The MDIC, through its public-private partnership between government and regulatory agencies, non-profits, and the medical device industry, aims to advance regulatory science and bring innovative technologies to patients. MDIC coordinates the development of methods, tools, and resources used in managing the medical device life cycle to improve patient access to cutting-edge medical technology.

About the Medical Device Innovation Consortium

Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market.

About Life Science Partner Executive Search

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

More information is available here.

Josh Lewis, PhD Joins Life Science Partner as Executive Search Associate

 

Life Science Partner is pleased to announce the addition of our newest team member, Josh Lewis, PhD. Josh joins us as Executive Search Associate and is responsible for managing our search operations and firm operations, including our research programs and technology platforms.

“Josh brings an additional layer of scientific and technological expertise to the Life Science Partner team,” states Tom Callaway, MD, Founder and President. “We are delighted to have Josh onboard to help us continue to deliver on our promise of a premium, scientifically expert, technology-driven executive recruiting service.”

Prior to joining LSP, Josh earned his PhD in Biochemistry, Cell and Developmental Biology from Emory University in Atlanta, where his research focused on cell adhesion molecules and cell membrane composition, with clinical applications ranging from oncology to rare skin diseases.

Josh applies his rigorous scientific training to our search process, building upon our clinical expertise and our carefully executed, partner-led process. As a scientist and engineer, Josh understands the technologies and market forces that are important to our clients. He also applies his training in complex research endeavors to ensure our identification and assessment of candidates reflect a level of intellectual rigor unmatched in the industry.

We also are pleased to leverage Josh’s technology background and coding skills, combined with the latest developments in data management and artificial intelligence, to continually reimagine how we use technology to magnify our networks and improve our service.

During graduate school, Josh lead the Emory Science Advocacy Network, which promotes the interests of the biomedical research community to Congress. Josh earned his PhD from Emory University in Atlanta and his undergraduate degree in Biological Engineering from the University of Georgia. Josh enjoys photography, hiking, and public policy.

 

 

Recruiting Transformational Leaders™

Life Science Partner is a specialized executive search firm that recruits transformational leaders for healthcare and life sciences companies. Our high-touch, partner-led process ensures an exceptional level of service, while our backgrounds as physicians and industry executives enable us to efficiently deliver the brightest candidates in the medical device, biopharmaceuticals, diagnostics, and healthcare technology fields.

www.lifesciencepartner.com